Congenital epidermolysis bullosa: A review

C. Siañez-González, R. Pezoa-Jares, J. C. Salas-Alanis

Research output: Contribution to journalLiterature review

16 Citations (Scopus)

Abstract

Epidermolysis bullosa is a group of hereditary diseases affecting 1 in 17 000 live births worldwide. It consists of blistering of the skin and mucous membranes in response to minimal trauma. The disorder seriously affects the patient's quality of life. Diagnosis is based on immunofluorescence mapping and electron microscopy. Treatment is symptomatic, although new cellular and molecular therapies are currently under investigation. This review covers aspects of the molecular biology, clinical presentation, diagnosis, and treatment of epidermolysis bullosa relevant to improving the care for affected patients.
Original languageEnglish
Pages (from-to)842-856
Number of pages15
JournalActas Dermo-Sifiliograficas
DOIs
Publication statusPublished - 1 Jan 2009
Externally publishedYes

Fingerprint

Epidermolysis Bullosa
Inborn Genetic Diseases
Live Birth
Fluorescence Microscopy
Molecular Biology
Electron Microscopy
Patient Care
Mucous Membrane
Therapeutics
Quality of Life
Skin
Wounds and Injuries

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Histology
  • Dermatology

Cite this

Siañez-González, C., Pezoa-Jares, R., & Salas-Alanis, J. C. (2009). Congenital epidermolysis bullosa: A review. Actas Dermo-Sifiliograficas, 842-856. https://doi.org/10.1016/S1578-2190(09)70554-2
Siañez-González, C. ; Pezoa-Jares, R. ; Salas-Alanis, J. C. / Congenital epidermolysis bullosa: A review. In: Actas Dermo-Sifiliograficas. 2009 ; pp. 842-856.
@article{4bef6312024140829b8cd86afc539d4b,
title = "Congenital epidermolysis bullosa: A review",
abstract = "Epidermolysis bullosa is a group of hereditary diseases affecting 1 in 17 000 live births worldwide. It consists of blistering of the skin and mucous membranes in response to minimal trauma. The disorder seriously affects the patient's quality of life. Diagnosis is based on immunofluorescence mapping and electron microscopy. Treatment is symptomatic, although new cellular and molecular therapies are currently under investigation. This review covers aspects of the molecular biology, clinical presentation, diagnosis, and treatment of epidermolysis bullosa relevant to improving the care for affected patients.",
author = "C. Sia{\~n}ez-Gonz{\'a}lez and R. Pezoa-Jares and Salas-Alanis, {J. C.}",
year = "2009",
month = "1",
day = "1",
doi = "10.1016/S1578-2190(09)70554-2",
language = "English",
pages = "842--856",
journal = "Actas Dermo-Sifiliograficas",
issn = "0001-7310",
publisher = "Ediciones Doyma, S.L.",

}

Siañez-González, C, Pezoa-Jares, R & Salas-Alanis, JC 2009, 'Congenital epidermolysis bullosa: A review', Actas Dermo-Sifiliograficas, pp. 842-856. https://doi.org/10.1016/S1578-2190(09)70554-2

Congenital epidermolysis bullosa: A review. / Siañez-González, C.; Pezoa-Jares, R.; Salas-Alanis, J. C.

In: Actas Dermo-Sifiliograficas, 01.01.2009, p. 842-856.

Research output: Contribution to journalLiterature review

TY - JOUR

T1 - Congenital epidermolysis bullosa: A review

AU - Siañez-González, C.

AU - Pezoa-Jares, R.

AU - Salas-Alanis, J. C.

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Epidermolysis bullosa is a group of hereditary diseases affecting 1 in 17 000 live births worldwide. It consists of blistering of the skin and mucous membranes in response to minimal trauma. The disorder seriously affects the patient's quality of life. Diagnosis is based on immunofluorescence mapping and electron microscopy. Treatment is symptomatic, although new cellular and molecular therapies are currently under investigation. This review covers aspects of the molecular biology, clinical presentation, diagnosis, and treatment of epidermolysis bullosa relevant to improving the care for affected patients.

AB - Epidermolysis bullosa is a group of hereditary diseases affecting 1 in 17 000 live births worldwide. It consists of blistering of the skin and mucous membranes in response to minimal trauma. The disorder seriously affects the patient's quality of life. Diagnosis is based on immunofluorescence mapping and electron microscopy. Treatment is symptomatic, although new cellular and molecular therapies are currently under investigation. This review covers aspects of the molecular biology, clinical presentation, diagnosis, and treatment of epidermolysis bullosa relevant to improving the care for affected patients.

U2 - 10.1016/S1578-2190(09)70554-2

DO - 10.1016/S1578-2190(09)70554-2

M3 - Literature review

SP - 842

EP - 856

JO - Actas Dermo-Sifiliograficas

JF - Actas Dermo-Sifiliograficas

SN - 0001-7310

ER -

Siañez-González C, Pezoa-Jares R, Salas-Alanis JC. Congenital epidermolysis bullosa: A review. Actas Dermo-Sifiliograficas. 2009 Jan 1;842-856. https://doi.org/10.1016/S1578-2190(09)70554-2